The largest database of trusted experimental protocols

F2hfd1

Manufactured by Oriental Yeast
Sourced in Japan

The F2HFD1 is a laboratory equipment designed for specific laboratory functions. It serves a core function, but a detailed description without interpretation or extrapolation is not available.

Automatically generated - may contain errors

6 protocols using f2hfd1

1

Generation and Characterization of CREBH Transgenic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type (WT) C57/BL6J mice were obtained from CLEA Japan. To generate CREBH Tg mice, cDNAs encoding the rat Pck1 promoter, active human CREBH (amino acids 1–320), and the 3′ polyadenylation signal of human growth hormone were microinjected into C57BL6J eggs [21] (link). Creb3l3tm1.1Sad/J (CREBH null) mice [18] (link) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). All mice were housed in a pathogen-free barrier facility under a 12-h light/dark cycle and given free access to water. Mice were fed a normal chow diet (MF: Oriental Yeast, Tokyo, Japan) or a lithogenic diet (LD) (16.5% fat, 1.25% cholesterol, 0.5% cholic acid (CA); F2HFD1; Oriental Yeast) (F2HFD1: Oriental Yeast, Tokyo, Japan) [22] (link) for 2 weeks. All animal husbandry and experimental protocols conformed to the University of Tsukuba Regulations of Animal Experiments and were approved by the Animal Experiment Committee of the University of Tsukuba.
+ Open protocol
+ Expand
2

Glucose-Induced Atherosclerosis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Specific pathogen-free 7-week-old female C57BL/6J mice were purchased from CLEA Japan (Tokyo, Japan). Female mice are known to be more susceptible to atherosclerotic lesion formation than males [12 (link),13 (link)]. After acclimatized with a standard rodent chow (MF; Oriental Yeast, Tokyo, Japan) for 1 week, the mice (17.7 ± 0.2 g, n = 16) were assigned to 2 groups, i.e., glucose-administered (G, n = 8) and water-administered (W, n = 8), ensuring equal weight average. The G group mice received a 20% glucose solution (50 mg glucose/mouse) by oral gavage twice a day (08:00 and 16:00), 6 days a week for 20 weeks. The W group mice similarly received distilled water alone. During the 20-week administration period, both groups of mice were fed an atherogenic diet (F2HFD1, Oriental Yeast) based on Paigen’s formulation [14 (link)]. The mice were housed in standard plastic cages (235 × 325 × 170 [h] mm; 4 mice/cage) with paper chip bedding and maintained in a temperature controlled room (22–24°C) with a 14-h light (06:00–20:00 h)/10-h dark cycle, with free access to food and water. The cages, bedding, food, and water bottles were changed weekly.
+ Open protocol
+ Expand
3

Adropin Infusion in Hyperlipidemic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Research Council, with protocols approved by the Institutional Animal Care and Use Committee of Tokyo University of Pharmacy and Life Sciences (No. L17-22, 24 April 2017). A total of 22 male spontaneously hyperlipidemic Apoe−/− mice (BALB/c. KOR/StmSlc-Apoeshl mice) at 8 weeks old were purchased from Japan SLC (Hamamatsu, Japan) and fed a normal diet. At 13 weeks old, a high-cholesterol diet containing 1.25% cholesterol, 3.0% lard, and 1.625% glucose (F2HFD1; Oriental Yeast, Tokyo, Japan) was started [39 (link),40 (link),41 (link),44 (link),45 (link),46 (link),47 (link),48 (link),49 (link)]. At 17 weeks old, six mice were sacrificed as pre-infusion controls. The remaining 16 mice were divided into three groups of six, five, and five mice, and infused using osmotic minipumps (Alzet Model 1002; Durect, Cupertino, CA, USA) for 4 weeks with three doses of adropin (0, 5, 10 μg/kg/h), respectively. Doses of adropin were selected based on previous data [5 (link),9 (link),28 (link),29 (link)]. Pumps were implanted subcutaneously into the dorsum, and replaced once every 2 weeks under medetomidine-midazolam-butorphanol anesthesia [45 (link)].
+ Open protocol
+ Expand
4

High-Fat Diet Feeding in ApoE-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The animals used in this study were treated in accordance with the Guidelines for Animal Experiments published by the Japanese Association for Laboratory Animal Science, ARRIVE guidelines and the Animal Research Center of the Okayama University of Science, Japan. All experiments were approved by the Animal Care and Use Committee of the Okayama University of Science. Efforts were made to minimize the number of animals used and animal suffering. Mice were housed in a specific pathogen-free room under controlled humidity (50%) and temperature (22 °C) conditions with 12-h light–dark cycles. Male, 4-week-old C57BL/6 J mice were purchased from Shimizu Experimental Animals (Kyoto, Japan) and habituated to a colony for 1 week. ApoE−/− mice (B6.129P2-Apoe tmlUnc, backcrossing at least 10 generations to C57BL/6 J inbred mice; The Jackson Laboratory, Bar Harbor, ME, USA) and C57BL/6 J mice were fed a high-fat diet (HFD; F2HFD1, Oriental Yeast Co., Ltd., Tokyo, Japan) containing 1.25% cholesterol, cocoa butter fat, and 3.0% lard, for either 5 or 10 weeks. In total, 183 mice were used in these experiments (29 C57BL/6 J mice and 154 ApoE−/− mice).
+ Open protocol
+ Expand
5

Atherosclerosis in ApoE-/- and Ku80-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mouse experiments were approved by the Institutional Animal Care and Use Committees of Hiroshima University. All animal procedures were performed under the guidelines established by the Animal Experimentation Committees of Hiroshima University. All the animal experiments in this study complied with the ARRIVE guidelines. ApoE−/− mice on C57BL/6 J background (Stock #002052) were purchased from The Jackson Laboratory (ME, USA). Ku80−/− 129/Svj mice were generously provided by Dr. Noboru Motoyama with permission from Dr. André Nussenzweig26 (link). The Ku80−/− 129/Svj mice were backcrossed into a C57BL/6 J background and then cross-bred with the ApoE−/− mice to generate Ku80+/−ApoE−/− mice. Their genotypes were identified by polymerase chain reaction (PCR). The primers used for genotyping were as follows: Ku80 KO, forward, 5′ AGCTTCCACCCTCTAGAGAT 3′; Ku80 wild-type, forward, 5′ TAAAGCGCATGCTCCAGACT 3′; and Ku80 complement, reverse, 5′ ATTGTGATGTGTGGGACACG 3′. The male mice were fed with a high-fat diet (F2HFD1: fat, 36% of total kcal; cholesterol, 1.25%; Oriental Yeast Co., Tokyo, Japan) starting from 60 days of age for either 2 or 4 weeks. All mice were housed under a 12-h light and dark cycle. The mice were asphyxiated by gaseous carbon dioxide, and the aorta was isolated from them.
+ Open protocol
+ Expand
6

Hyperlipidemic Mouse Model for β-Endorphin Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal experiments were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Tokyo University of Pharmacy and Life Sciences (no. L19-16). A total of 21 male spontaneously hyperlipidemic Apoe−/− mice (KOR/StmSlc-Apoeshl mice) were purchased from Japan SLC (Hamamatsu, Japan). Mice were fed a high cholesterol diet containing 1.25% cholesterol, 3.0% lard, and 1.625% glucose (F2HFD1, Oriental Yeast, Tokyo, Japan), starting at 13 weeks of age [2 (link), 29 (link)–37 (link), 39 (link), 40 (link)]. At 13 weeks of age, five mice were sacrificed as preinfusion controls. The remaining 16 were divided into two groups of eight each and were infused with saline (vehicle) or β-endorphin (5 μg/kg/h) using osmotic minipumps (Alzet Model 1002; Durect, Cupertino, CA, USA) for 4 weeks. Doses of β-endorphin were selected based on others' previous data and our preliminary data [32 (link)–35 (link)]. Once every 2 weeks, the minipumps were implanted subcutaneously into the dorsum under medetomidine-midazolam-butorphanol anesthesia (0.3 mg/kg, 4.0 mg/kg, and 5.0 mg/kg, respectively, intraperitoneal injection).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!